RTX (NYSE:RTX) shares are down on Wednesday as the company is advancing its technology under a DARPA contract.



The stock’s decline comes as the broader market is experiencing gains, with the S&amp;P 500 up 0.69% today.



<h2>DARPA Contract Fuels RTX Military Tech Advancement</h2>



RTX’s BBN Technologies has secured a contract from the Defense Advanced Research Projects Agency (DARPA) to develop long-range X-ray imaging algorithms. 



This initiative aims to enhance situational awareness for service members by reconstructing hidden geometries of objects from distances nearing a kilometer, a significant advancement in military technology.



The project will utilize advanced mathematical modeling and image analysis to improve visibility of hard-to-access objects, even when data is incomplete. 



The work will be conducted in collaboration with the Georgia Institute of Technology and is expected to yield tools that provide actionable insights into potential threats from a safe distance.



<h2>Major German Defense Contract Win</h2>



Today, the company announced a significant contract with the German Armed Forces for its Raytheon ELCAN division.



This contract, part of a surge in European demand, involves an innovative configuration that includes an Aimpoint® reflex sight for enhanced versatility in combat scenarios. The total value of these orders across Europe since August 2024 surpasses 193 million euros.



<h2>RTX Faces Short-Term Weakness in Technical Indicators</h2>



The broader market is experiencing positive momentum, with the Technology sector leading gains at 1.75%. Despite this, RTX’s shares are sliding, indicating that company-specific factors may be influencing its performance.



The stock is currently trading 1.40% below its 20-day simple moving average (SMA) and is 4.5% below its 100-day SMA, suggesting some short-term weakness. Over the past 12 months, shares have increased approximately 74%, and they are currently positioned closer to their 52-week highs than lows.



The RSI is at 44.45, which is considered neutral territory, while MACD is at 0.15, below its signal line at 0.22, indicating bearish pressure on the stock. The combination of neutral RSI and bearish MACD suggests mixed momentum.



<ul>
<li>Key Resistance: $206.50</li>



<li>Key Support: $180.00</li>
</ul>



<h2>RTX Financial Update and Analyst Ratings Ahead</h2>



RTX is slated to provide its next financial update on April 21, 2026.



<ul>
<li>EPS Estimate: $1.51 (Up from $1.47)</li>



<li>Revenue Estimate: $21.39 billion (Up from $20.31 billion)</li>



<li>Valuation: P/E of 40.0x (Indicates premium valuation)</li>
</ul>



Analyst Consensus &amp; Recent Actions: The stock carries a Buy Rating with an average price target of $186.43. Recent analyst moves include:



<ul>
<li>Citigroup: Buy (Raises Target to $238.00) (Feb. 5)</li>



<li>JP Morgan: Overweight (Raises Target to $215.00) (Jan. 28)</li>



<li>RBC Capital: Outperform (Raises Target to $230.00) (Jan. 28)</li>
</ul>



<h2>RTX Shares Dip Despite Market Gains</h2>



RTX Price Action: Rtx shares were down 1.40% at $195.69 at the time of publication on Wednesday, according to Benzinga Pro data.



Photo by T. Schneider via Shutterstock

ARKX

RTXG

RTX (NYSE:RTX) shares fell 1.40% to $195.69 despite broader market gains, as the company advances technology under a DARPA contract for long-range X-ray imaging. This initiative aims to enhance military situational awareness. Additionally, RTX secured a significant contract with the German Armed Forces, valued over 193 million euros. Despite a 74% increase in shares over the past year, technical indicators show short-term weakness, with the stock trading below its moving averages. RTX's next financial update is scheduled for April 21, 2026, with a Buy rating from analysts and a price target of $186.43.

RTX Wins DARPA Deal, Sparks Long-Term Potential